JP2018115201A5 - - Google Patents

Download PDF

Info

Publication number
JP2018115201A5
JP2018115201A5 JP2018061990A JP2018061990A JP2018115201A5 JP 2018115201 A5 JP2018115201 A5 JP 2018115201A5 JP 2018061990 A JP2018061990 A JP 2018061990A JP 2018061990 A JP2018061990 A JP 2018061990A JP 2018115201 A5 JP2018115201 A5 JP 2018115201A5
Authority
JP
Japan
Prior art keywords
atoms
substituted
unsubstituted
unbranched
branched alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018061990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018115201A (ja
JP6763904B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018115201A publication Critical patent/JP2018115201A/ja
Publication of JP2018115201A5 publication Critical patent/JP2018115201A5/ja
Application granted granted Critical
Publication of JP6763904B2 publication Critical patent/JP6763904B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018061990A 2011-05-23 2018-03-28 ピリジン−及びピラジン誘導体 Expired - Fee Related JP6763904B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161488997P 2011-05-23 2011-05-23
US61/488,997 2011-05-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016124235A Division JP2016196492A (ja) 2011-05-23 2016-06-23 ピリジン−及びピラジン誘導体

Publications (3)

Publication Number Publication Date
JP2018115201A JP2018115201A (ja) 2018-07-26
JP2018115201A5 true JP2018115201A5 (OSRAM) 2020-08-13
JP6763904B2 JP6763904B2 (ja) 2020-09-30

Family

ID=45976540

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014512837A Expired - Fee Related JP6054954B2 (ja) 2011-05-23 2012-04-11 ピリジン−及びピラジン誘導体
JP2016124235A Pending JP2016196492A (ja) 2011-05-23 2016-06-23 ピリジン−及びピラジン誘導体
JP2018061990A Expired - Fee Related JP6763904B2 (ja) 2011-05-23 2018-03-28 ピリジン−及びピラジン誘導体

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2014512837A Expired - Fee Related JP6054954B2 (ja) 2011-05-23 2012-04-11 ピリジン−及びピラジン誘導体
JP2016124235A Pending JP2016196492A (ja) 2011-05-23 2016-06-23 ピリジン−及びピラジン誘導体

Country Status (22)

Country Link
US (1) US9273029B2 (OSRAM)
EP (1) EP2714677B1 (OSRAM)
JP (3) JP6054954B2 (OSRAM)
KR (1) KR101581522B1 (OSRAM)
CN (1) CN103748086B (OSRAM)
AU (1) AU2012259333B2 (OSRAM)
BR (1) BR112013029640A2 (OSRAM)
CA (1) CA2832605C (OSRAM)
DK (1) DK2714677T3 (OSRAM)
EA (1) EA023364B1 (OSRAM)
ES (1) ES2699256T3 (OSRAM)
HR (1) HRP20181884T1 (OSRAM)
IL (1) IL229528A (OSRAM)
LT (1) LT2714677T (OSRAM)
MX (1) MX352975B (OSRAM)
PL (1) PL2714677T3 (OSRAM)
PT (1) PT2714677T (OSRAM)
RS (1) RS58015B1 (OSRAM)
SG (1) SG194105A1 (OSRAM)
SI (1) SI2714677T1 (OSRAM)
WO (1) WO2012161877A1 (OSRAM)
ZA (1) ZA201307429B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2714677T3 (pl) * 2011-05-23 2019-02-28 Merck Patent Gmbh Pochodne pirydynowe i pirazynowe
GB201303109D0 (en) 2013-02-21 2013-04-10 Domainex Ltd Novel pyrimidine compounds
LT3030554T (lt) * 2013-08-07 2018-05-10 Merck Patent Gmbh Piperidin-karbamido dariniai
AU2014361798B2 (en) 2013-12-13 2020-06-11 Dana-Farber Cancer Institute, Inc. Methods to treat lymphoplasmacytic lymphoma
US9908872B2 (en) 2013-12-13 2018-03-06 Dana-Farber Cancer Institute, Inc. Methods to treat lymphoplasmacytic lymphoma
EP3105225A1 (en) * 2014-02-12 2016-12-21 iTeos Therapeutics Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
SG11201608708WA (en) 2014-05-15 2016-11-29 Iteos Therapeutics Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors
TW201613916A (en) 2014-06-03 2016-04-16 Gilead Sciences Inc TANK-binding kinase inhibitor compounds
CN106715419A (zh) 2014-09-26 2017-05-24 吉利德科学公司 用作tank‑结合激酶抑制剂化合物的氨基三嗪衍生物
WO2016057338A1 (en) * 2014-10-06 2016-04-14 Takeda Pharmaceutical Company Limited Heteroarylamide inhibitors of tbk1
EP3715346B1 (en) 2014-10-22 2024-01-03 Dana-Farber Cancer Institute, Inc. Thiazolyl-containing compounds for treating proliferative diseases
MA41598A (fr) * 2015-02-25 2018-01-02 Constellation Pharmaceuticals Inc Composés thérapeutiques de pyridazine et leurs utilisations
CN107635990A (zh) 2015-03-17 2018-01-26 辉瑞公司 新型3‑吲哚取代的衍生物、药物组合物及使用方法
WO2017025868A1 (en) 2015-08-10 2017-02-16 Pfizer Inc. 3-indol substituted derivatives, pharmaceutical compositions and methods for use
AU2016370916A1 (en) 2015-12-17 2018-06-07 Gilead Sciences, Inc. Tank-binding kinase inhibitor compounds
WO2017102091A1 (en) 2015-12-18 2017-06-22 Bayer Pharma Aktiengesellschaft Heteroarylbenzimidazole compounds
WO2017207534A1 (en) 2016-06-03 2017-12-07 Bayer Pharma Aktiengesellschaft Substituted heteroarylbenzimidazole compounds
DK3971177T3 (da) 2016-07-20 2024-07-15 Novartis Ag Aminopyridin-derivater og anvendelse deraf som selektive ALK-2-inhibitorer
DE102016113714A1 (de) 2016-07-26 2018-02-01 Rosa Karl Transfektionsverfahren mit nicht-viralen Genliefersystemen
GB201702947D0 (en) 2017-02-23 2017-04-12 Domainex Ltd Novel compounds
TWI771410B (zh) * 2017-04-27 2022-07-21 日商石原產業股份有限公司 N-(4-吡啶基)菸鹼醯胺化合物或其鹽
CN115038443A (zh) 2019-11-22 2022-09-09 因西特公司 包含alk2抑制剂和jak2抑制剂的组合疗法
WO2021257532A1 (en) 2020-06-16 2021-12-23 Incyte Corporation Alk2 inhibitors for the treatment of anemia
US20230382901A1 (en) * 2020-10-09 2023-11-30 Napa Therapeutics Ltd. Heteroaryl amide inhibitors of cd38
CN116099004B (zh) * 2022-12-30 2024-01-30 深圳开悦生命科技有限公司 Rna解旋酶dhx33抑制剂在制备用于治疗膀胱癌的药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
SE0102439D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
SE0102438D0 (sv) 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
SE0203752D0 (sv) * 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
SE0203754D0 (sv) 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
CN1933838A (zh) * 2004-02-12 2007-03-21 默克公司 作为代谢型谷氨酸受体-5调节剂的联吡啶酰胺
TW200800203A (en) 2006-03-08 2008-01-01 Astrazeneca Ab New use
EP2016075A1 (en) 2006-05-03 2009-01-21 AstraZeneca AB Thiazole derivatives and their use as anti-tumour agents
WO2009030890A1 (en) 2007-09-03 2009-03-12 University Court Of The University Of Dundee Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma
AU2008315746A1 (en) 2007-10-25 2009-04-30 Astrazeneca Ab Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
WO2009122180A1 (en) 2008-04-02 2009-10-08 Medical Research Council Pyrimidine derivatives capable of inhibiting one or more kinases
AU2009327357C1 (en) 2008-12-19 2017-02-02 Vertex Pharmaceuticals Incorporated Pyrazine derivatives useful as inhibitors of ATR kinase
GB0903759D0 (en) 2009-03-04 2009-04-15 Medical Res Council Compound
WO2011089416A1 (en) 2010-01-19 2011-07-28 Astrazeneca Ab Pyrazine derivatives
PL2714677T3 (pl) * 2011-05-23 2019-02-28 Merck Patent Gmbh Pochodne pirydynowe i pirazynowe

Similar Documents

Publication Publication Date Title
JP2018115201A5 (OSRAM)
JP2016196492A5 (OSRAM)
JP2019031560A5 (OSRAM)
JP2010532768A5 (OSRAM)
JP2018127459A5 (OSRAM)
JP2016506369A5 (OSRAM)
JP2016526558A5 (OSRAM)
JP2016006118A5 (OSRAM)
JP2016530259A5 (OSRAM)
JP2016515560A5 (OSRAM)
JP2016056183A5 (OSRAM)
JP2016503797A5 (OSRAM)
JP2014518884A5 (OSRAM)
JP2016513660A5 (OSRAM)
JP2015511613A5 (OSRAM)
JP2012092103A5 (OSRAM)
JP2011530545A5 (OSRAM)
JP2015508103A5 (OSRAM)
JP2007514773A5 (OSRAM)
JP2012530758A5 (OSRAM)
JP2013544276A5 (OSRAM)
JP2017501237A5 (OSRAM)
JP2016531126A5 (OSRAM)
JP2017537937A5 (OSRAM)
HRP20201985T1 (hr) Piridonski spoj kao c-met inhibitor